Regorafenib (01276.HK): injection SHR-A1904 included in the list of breakthrough therapeutic drugs by the Drug Evaluation Center

Wisdom Finance APP News, Henan Ruyi Medicine (01276.HK) issued an announcement recently. Jiangsu Henan Ruyi Medicine Co., Ltd. (hereinafter referred to as "the Company") and its subsidiary, Shanghai Henan Ruyi Medicine Co., Ltd., have had their injection SHR-A1904 included in the list of breakthrough therapeutic varieties by the National Drug Evaluation Center of the State Food and Drug Administration (hereinafter referred to as "the Drug Evaluation Center").